ITC Report issue

For profit Phase 4
Founded: New York NY United States (1969)
Status: No NME R&D (1969)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
None

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

ITC Imaging, LLC

Active Ingredients

Drugs in Phase 4 Trials (3)

Key: ITC (0) Acquired (3)

acetylsalicylic acid (aspirin) (2 trials)

clopidogrel (plavix) (2 trials)

prasugrel (effient) (1 trial)

Drugs in Other Trials (2)

Key: ITC (0) Acquired (2)

desmopressin (ddavp) (1 trial)

platelets (1 trial)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 5
  • # of Trial APIs: 5